HS
HighVista Strategies Portfolio holdings
AUM
$272M
1-Year Return
24.34%
This Quarter Return
+1.03%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$269M
AUM Growth
-$21.2M
(-7.3%)
Cap. Flow
-$10.1M
Cap. Flow
% of AUM
-3.75%
Top 10 Holdings %
Top 10 Hldgs %
26.35%
Holding
168
New
26
Increased
41
Reduced
37
Closed
31
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$3.1M |
| 2 |
Guardant Health
GH
|
$2.88M |
| 3 |
Janux Therapeutics
JANX
|
$2.48M |
| 4 |
Apellis Pharmaceuticals
APLS
|
$2.32M |
| 5 |
Dynavax Technologies
DVAX
|
$1.73M |
Top Sells
| 1 |
CTLT
CATALENT, INC.
CTLT
|
$4.58M |
| 2 |
Capri Holdings
CPRI
|
$3.3M |
| 3 |
Amgen
AMGN
|
$3.25M |
| 4 |
Maplebear
CART
|
$3.2M |
| 5 |
GE Vernova
GEV
|
$2.6M |
Sector Composition
| 1 | Healthcare | 43.86% |
| 2 | Technology | 16.73% |
| 3 | Consumer Discretionary | 7.18% |
| 4 | Communication Services | 5.42% |
| 5 | Industrials | 4.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Pharvaris
PHVS
$1.41B
| $436K | 0.16% |
22,768
| – | – |
|
127
Disc Medicine
IRON
$2.09B
| $409K | 0.15% |
6,458
-3,107
| -32% | -$197K |
|
128
Kura Oncology
KURA
$706M
| $402K | 0.15% |
46,181
+25,020
| +118% | +$218K |
|
129
Cullinan Oncology
CGEM
$408M
| $388K | 0.14% |
31,893
| – | – |
|
130
JD.com
JD
$43.9B
| $374K | 0.14% |
10,783
-3,500
| -25% | -$121K |
|
131
Mirum Pharmaceuticals
MIRM
$3.73B
| $370K | 0.14% |
8,942
-4,629
| -34% | -$191K |
|
|
ABVX
132
Abivax
ABVX
$6.47B
| $359K | 0.13% |
49,064
| – | – |
|
133
Kymera Therapeutics
KYMR
$3.02B
| $351K | 0.13% |
8,733
-4,010
| -31% | -$161K |
|
134
Akero Therapeutics
AKRO
$3.52B
| $349K | 0.13% |
+12,529
| New | +$349K |
|
135
Erasca
ERAS
$420M
| $341K | 0.13% |
+135,667
| New | +$341K |
|
136
Tyra Biosciences
TYRA
$647M
| $333K | 0.12% |
23,941
+7,863
| +49% | +$109K |
|
137
KalVista Pharmaceuticals
KALV
$765M
| $282K | 0.1% |
33,305
| – | – |
|
138
Autodesk
ADSK
$68.1B
| – | – |
-7,500
| Closed | -$2.07M |
|
139
AerCap
AER
$21.9B
| – | – |
-17,000
| Closed | -$1.61M |
|
140
Alnylam Pharmaceuticals
ALNY
$59.4B
| – | – |
-1,551
| Closed | -$427K |
|
141
Autoliv
ALV
$9.63B
| – | – |
-7,200
| Closed | -$672K |
|
|
142
Amgen
AMGN
$151B
| – | – |
-10,101
| Closed | -$3.25M |
|
143
AnaptysBio
ANAB
$590M
| – | – |
-15,574
| Closed | -$522K |
|
144
KE Holdings
BEKE
$21.9B
| – | – |
-30,507
| Closed | -$607K |
|
145
Baidu
BIDU
$33.8B
| – | – |
-5,386
| Closed | -$567K |
|
|
146
Maplebear
CART
$11.7B
| – | – |
-78,500
| Closed | -$3.2M |
|
147
Celldex Therapeutics
CLDX
$1.51B
| – | – |
-8,981
| Closed | -$305K |
|
|
148
Capri Holdings
CPRI
$2.59B
| – | – |
-77,700
| Closed | -$3.3M |
|
149
CRH
CRH
$74.9B
| – | – |
-11,100
| Closed | -$1.03M |
|
150
Elevance Health
ELV
$69.4B
| – | – |
-2,500
| Closed | -$1.3M |
|